| HOME >> BIOLOGY >> TECHNOLOGY |
- Sales Grow 73% over Same Quarter Last Year -
- FY08 Revenue Guidance Raised -
- Conference Call to be Held Today at 10:00 am Central Time -
MINNEAPOLIS, Feb. 11 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, today reported record net sales of $3.7 million for the third quarter of fiscal 2008 ended December 31, 2007, up 73% from $2.2 million in the year ago quarter. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales during the third fiscal quarter increased by approximately 65%.
For the three months ended December 31, 2007, sales to customers in the U.S. increased to $2.0 million from $396,000 in the year ago period. Sales to customers outside the U.S. for the three months ended December 31, 2007 and 2006 were $1.8 million in each period. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales to customers outside of the U.S. declined by approximately 10%.
"Our relatively new U.S. sales force has begun to hit stride by adding
over 100 new customer relationships for the Urgent(R) PC neuromodulation
system, bringing to more than 300 the total number of active U.S. customers
who purchased our Urgent PC system or additional lead sets during our third
fiscal quarter," said David B. Kaysen, Uroplasty's President and CEO. "As a
result, we had exceptional third quarter revenue growth and are able to
increase our revenue guidance for the full fiscal year. The Urgent PC is
gaining rapid acceptance within our target market and doctors report very
high patient satisfaction rates. Due to the strong growth in the third
quarter in active customers for and the positive feedback on the Urgent PC,
our sales team will focus a large amount of their time over the near term
on building utilization
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Uroplasty to Host Third Quarter Conference Call on February 11
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |